Skip to content
★ Sign in to follow
JV

J. van der Meijs

Pharming Group N.V.
Insider activity · 24 months2 buys0 sales
Total declarations
16
Company
1
▲ Purchases (16 ops.)
€53k
▼ Sales (0 ops.)
—

Latest filing: trade of 28 May 2026 for Pharming Group N.V.. The register gives no publication date.

Filing timeline

BuySale
J. van der Meijs

Insider track record

Disclosed buys
16
Disclosed sells
0
Signal history

Closed purchases

Market purchases
16
Positive at T+90
75%
Median T+90
+29.3%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 27 Oct 2022 · 1473 days ago · €9,174
    +12.0%
    Entry €0.99 · Close at T+365 €1.10
  • Filed 04 Aug 2022 · 1557 days ago · €7,500
    +25.5%
    Entry €0.90 · Close at T+365 €1.13
  • Filed 25 May 2022 · 1628 days ago · €9,300
    +52.3%
    Entry €0.77 · Close at T+365 €1.18
  • Filed 05 Aug 2021 · 1921 days ago · €13k
    +6.3%
    Entry €0.91 · Close at T+365 €0.97

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

J. van der Meijs: trading record in brief

J. van der Meijs appears in our data through filings on Pharming Group N.V. shares, published by AFM. In total, 16 filings cover trades dated from 5 August 2021 to 28 May 2026.

On the market, this insider has only ever bought: 16 purchases, €53k in total. The totals exclude 10 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and no sales on the market.

Half of the purchases are above €8,337 and half below. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +29.3%. This is a record of the past, not a forecast.

The record was last updated on 6 June 2026 with an open-market purchase in Pharming Group N.V. This summary is built from AFM disclosures alone and does not predict where the share price will go.

Companies and markets linked to J. van der Meijs

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    38,583 shares0Gewoon aandeelAFM:194921
    Canonical exit: 26 Aug 2026 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    31,400 shares0Gewoon aandeelAFM:176244
    Canonical exit: 8 Sept 2025 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    8,487 shares0Gewoon aandeelAFM:165349
    Canonical exit: 29 Jan 2025 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    8,487 shares0Gewoon aandeelAFM:161829
    Canonical exit: 30 Oct 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    9,553 shares0Gewoon aandeelAFM:159044
    Canonical exit: 27 Aug 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    7,419 shares0Gewoon aandeelAFM:155756
    Canonical exit: 13 Jun 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    7,234 shares0Gewoon aandeelAFM:149884
    Canonical exit: 29 Jan 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    7,234 shares0Gewoon aandeelAFM:146144
    Canonical exit: 1 Nov 2023 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    7,446 shares0Gewoon aandeelAFM:143213
    Canonical exit: 22 Aug 2023 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    7,022 shares0Gewoon aandeelAFM:138776
    Canonical exit: 19 Jun 2023 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    €9,17429AFM
    9,760 shares@ €0.940.0% of flowGewoon aandeelAFM:132727
    Canonical exit: 25 Jan 2023 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    €7,50029AFM
    9,760 shares@ €0.76850.0% of flowGewoon aandeelAFM:128014
    Canonical exit: 2 Nov 2022 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    €9,30025AFM
    9,300 shares@ €1.0024.2% of flowGewoon aandeelAFM:125094
    Canonical exit: 23 Aug 2022 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.

    Same trade as the filing by L. Kruimer, counted once

    €7,49929AFM
    10,220 shares@ €0.73380.0% of flowGewoon aandeelAFM:122185
    Canonical exit: 22 Jun 2022 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.

    Same trade as the filing by L. Kruimer, counted once

    €7,50029AFM
    7,241 shares@ €1.03580.0% of flowGewoon aandeelAFM:116793
    Canonical exit: 26 Jan 2022 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    €13k29AFM
    12,068 shares@ €1.03580.0% of flowGewoon aandeelAFM:114822
    Canonical exit: 3 Nov 2021 (T+90)

16 of 14 declarations